Real-world clinical evidence of lazertinib use in acquired EGFR T790M mutated non-small cell lung cancer.

Sehhoon Park,Hyun Ae Jung,Se-Hoon Lee,Jin Seok Ahn,Myung-Ju Ahn,Jong-Mu Sun

Translational lung cancer research（2023）

引用 0|浏览3

暂无评分

摘要

Our result demonstrates the real-world clinical efficacy of lazertinib in acquired T790M mutation. Although dose reduction due to adverse events was not uncommon, it did not impair clinical efficacy of lazertinib.

查看译文

关键词

lazertinib use,lung cancer,real-world,non-small

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要